Biosenta Inc. ZRO
CNSX
| 06/30/2026 | 03/31/2026 | ||||
|---|---|---|---|---|---|
| Revenue | -95.83% | 2,300.00% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -95.83% | 2,300.00% | |||
| Cost of Revenue | -100.00% | 1,500.00% | |||
| Gross Profit | -100.00% | 700.00% | |||
| SG&A Expenses | 19.29% | 20.30% | |||
| Depreciation & Amortization | 0.00% | 0.00% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 15.37% | 17.42% | |||
| Operating Income | -16.47% | -16.33% | |||
| Income Before Tax | -53.62% | 9.90% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -53.62% | 9.90% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -53.62% | 9.90% | |||
| EBIT | -16.47% | -16.33% | |||
| EBITDA | -16.54% | -16.36% | |||
| EPS Basic | -196.58% | 10.00% | |||
| Normalized Basic EPS | -197.26% | 9.88% | |||
| EPS Diluted | -196.58% | 10.00% | |||
| Normalized Diluted EPS | -197.26% | 9.88% | |||
| Average Basic Shares Outstanding | -48.00% | 0.00% | |||
| Average Diluted Shares Outstanding | -48.00% | 0.00% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||